Prenatal alcohol exposure: Fetal programming and later life vulnerability to stress, depression and anxiety disorders

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 6, 2010, Pages 791-807

  Hellemans, Kim G C ^a,b   Sliwowska, Joanna H ^a   Verma, Pamela ^a   Weinberg, Joanne ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Animal models; Behavior; Depression; Fetal alcohol spectrum disorder; Fetal programming; HPA axis; Prenatal ethanol; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; IPSAPIRONE; MONOAMINE; NEUROTRANSMITTER; PROOPIOMELANOCORTIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ADAPTIVE BEHAVIOR; ANXIETY DISORDER; BEHAVIOR DISORDER; COMORBIDITY; DEPRESSION; DRUG RECEPTOR BINDING; FETAL ALCOHOL SYNDROME; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EVENT; MENTAL STRESS; NEUROBIOLOGY; NONHUMAN; PERSONAL EXPERIENCE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; REVIEW; SEX DIFFERENCE; SUBSTANCE ABUSE; TASK PERFORMANCE;

ANIMALS; ANXIETY DISORDERS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DEPRESSIVE DISORDER; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STRESS, PSYCHOLOGICAL;

EID: 77950629899     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.06.004     Document Type: Review

References (248)

1. Abel E.L. Prenatal effects of alcohol on adult learning in rats. Pharmacol. Biochem. Behav. 1979, 10(2):239-243.
2. Abel E.L. A further analysis of physiological changes in rats in the forced swim test. Physiol. Behav. 1994, 56(4):795-800.
3. Abel E.L., Dintcheff B.A. Effects of prenatal alcohol exposure on growth and development in rats. J. Pharmacol. Exp. Ther. 1978, 207(3):916-921.
4. Abel E.L., Hannigan J.H. Effects of chronic forced swimming and exposure to alarm substance: physiological and behavioral consequences. Physiol. Behav. 1992, 52(4):781-785.
5. Abel E.L., Hannigan J.H. The immobility response in the forced swim test: paradoxical effect of imipramine. Eur. J. Pharmacol. 1994, 258(3):261-264.
6. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998, 9(14):3301-3307.
7. Agid O., Kohn Y., Lerer B. Environmental stress and psychiatric illness. Biomed. Pharmacother. 2000, 54(3):135-141.
8. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 1994, 15(4):321-350.
9. Aguilera G., Kiss A., Liu Y., Kamitakahara A. Negative regulation of corticotropin releasing factor expression and limitation of stress response. Stress 2007, 10(2):153-161.
10. Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants. Horm. Behav. 2006, 50(4):534-538.
11. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR 2000, American Psychiatric Press, Inc., Washington, DC. 4th edition, text revision ed.
12. Anandam N., Felegi W., Stern J.M. In utero alcohol heightens juvenile reactivity. Pharmacol. Biochem. Behav. 1980, 13(4):531-535.
13. Anisman H., Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci. Biobehav. Rev. 2005, 29(4-5):525-546.
14. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch. Gen. Psychiatry 1985, 42(12):1193-1204.
15. Archer J. Tests for emotionality in rats and mice: a review. Anim. Behav. 1973, 21(2):205-235.
16. Astley S.J., Olson H.C., Kerns K., Brooks A., Aylward E.H., Coggins T.E., Davies J., Dorn S., Gendler B., Jirikowic T., Kraegel P., Maravilla K., Richards T. Neuropyschological and behavioral outcomes from a comprehensive magnetic resonance study of children. Can. J. Clin. Pharmacol. 2009, 16(1):178-201.
17. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 2004, 29(3):185-193.
18. Barr C.S., Newman T.K., Lindell S., Shannon C., Champoux M., Lesch K.P., et al. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch. Gen. Psychiatry 2004, 61(11):1146-1152.
19. Bernet C.Z., Stein M.B. Relationship of childhood maltreatment to the onset and course of major depression in adulthood. Depress. Anxiety 1999, 9(4):169-174.
20. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 1998, 28(3):309-369.
21. Bertoglio L.J., Joca S.R., Guimaraes F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav. Brain Res. 2006, 175(1):183-188.
22. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006, 7(2):137-151.
23. Board F., Wadeson R., Persky H. Depressive affect and endocrine functions; blood levels of adrenal cortex and thyroid hormones in patients suffering from depressive reactions. AMA Arch. Neurol. Psychiatry 1957, 78(6):612-620.
24. Bond N.W., Di Giusto E.L. Effects of prenatal alcohol consumption on open-field behaviour and alcohol preference in rats. Psychopharmacologia 1976, 46(2):163-165.
25. Bond N.W., Digiusto E.L. Effects of prenatal alcohol consumption on shock avoidance learning in rats. Psychol. Rep. 1977, 41(3 pt. 2):1269-1270.
26. Braddock L. The dexamethasone suppression test. Fact and artefact. Br. J. Psychiatry 1986, 148:363-374.
27. Bruijnzeel A.W., Repetto M., Gold M.S. Neurobiological mechanisms in addictive and psychiatric disorders. Psychiatr. Clin. North Am. 2004, 27(4):661-674.
28. Burd L., Klug M.G., Martsolf J.T., Kerbeshian J. Fetal alcohol syndrome: neuropsychiatric phenomics. Neurotoxicol. Teratol. 2003, 25(6):697-705.
29. Caldji C., Diorio J., Meaney M.J. Variations in maternal care in infancy regulate the development of stress reactivity. Biol. Psychiatry 2000, 48(12):1164-1174.
30. Calfa G., Bussolino D., Molina V.A. Involvement of the lateral septum and the ventral hippocampus in the emotional sequelae induced by social defeat: role of glucocorticoid receptors. Behav. Brain Res. 2007, 181(1):23-34.
31. Cameron O.G. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. Essent. Psychopharmacol. 2006, 7(1):24-34.
32. Cameron O.G., Abelson J.L., Young E.A. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol. Psychiatry 2004, 56(11):875-883.
33. Carneiro L.M., Diogenes J.P., Vasconcelos S.M., Aragao G.F., Noronha E.C., Gomes P.B., et al. Behavioral and neurochemical effects on rat offspring after prenatal exposure to ethanol. Neurotoxicol. Teratol. 2005, 27(4):585-592.
34. Carroll B.J. The dexamethasone suppression test for melancholia. Br. J. Psychiatry 1982, 140:292-304.
35. 1A receptor mRNA expression. J. Neurosci. 1993, 13:914.
36. Chernoff G.F. The fetal alcohol syndrome in mice: an animal model. Teratology 1977, 15(3):223-229.
37. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1994, 49(1):171-176.
38. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29(4-5):547-569.
39. Cryan J.F., Slattery D.A. Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 2007, 20(1):1-7.
40. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., et al. Chronic mild stress impact: are females more vulnerable?. Neuroscience 2005, 135(3):703-714.
41. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 1987, 43:113-173.
42. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., et al. Chronic stress and obesity: a new view of " comfort food" Proc. Natl. Acad. Sci. U.S.A. 2003, 100(20):11696-11701.
43. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: perspectives from affective neuroscience. Annu. Rev. Psychol. 2002, 53:545-574.
44. de Goeij D.C., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., Tilders F.J. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 1991, 53(2):150-159.
45. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6(6):463-475.
46. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19(3):269-301.
47. Deuschle M., Schweiger U., Weber B., Gotthardt U., Korner A., Schmider J., et al. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 1997, 82(1):234-238.
48. Deuschle M., Schweiger U., Gotthardt U., Weber B., Körner A., Schmider J., Standhardt H., Lammers C.H., Krumm B., Heuser I. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Biol. Psychiatry 1998, 43(10):762-766.
49. Dinan T. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. Hum. Psychopharmacol. 2001, 16(1):89-93.
50. Dinan T.G. Stress: the shared common component in major mental illnesses. Eur. Psychiatry 2005, 20(Suppl. 3):S326-S328.
51. Dinan T.G., Scott L.V. Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. J. Anat. 2005, 207(3):259-264.
52. Doig J., McLennan J.D., Gibbard W.B. Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder. J. Child Adolesc. Psychopharmacol. 2008, 18(4):365-371.
53. Druse M.J. Neurotransmitter function: changes associated with in utero alcohol exposure. Fetal Alcohol Syndrome: From Mechanisms to Prevention 1996, 171-189. CRC Press. E.L. Abel (Ed.).
54. Druse M.J., Kuo A., Tajuddin N. Effects of in utero ethanol exposure on the developing serotonergic system. Alcohol. Clin. Exp. Res. 1991, 15(4):678-684.
55. Elgen I., Bruaroy S., Laegreid L.M. Complexity of foetal alcohol or drug neuroimpairments. Acta Paediatr. 2007, 96(12):1730-1733.
56. Famy C., Streissguth A.P., Unis A.S. Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am. J. Psychiatry 1998, 155(4):552-554.
57. File S.E., Hyde J.R. Can social interaction be used to measure anxiety?. Br. J. Pharmacol. 1978, 62(1):19-24.
58. Fisher P.A., Gunnar M.R., Dozier M., Bruce J., Pears K.C. Effects of therapeutic interventions for foster children on behavioral problems, caregiver attachment, and stress regulatory neural systems. Ann. NY Acad. Sci. 2006, 1094:215-225.
59. Fisher P.A., Stoolmiller M., Gunnar M.R., Burraston B.O. Effects of a therapeutic intervention for foster preschoolers on diurnal cortisol activity. Psychoneuroendocrinology 2007, 32(8-10):892-905.
60. Flaherty C., Geary N. Contrast in consummatory behavior. Appetite 1993, 21(1):81.
61. Flaherty C.F., Turovsky J., Krauss K.L. Relative hedonic value modulates anticipatory contrast. Physiol. Behav. 1994, 55(6):1047-1054.
62. Forbes N.F., Stewart C.A., Matthews K., Reid I.C. Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol. Behav. 1996, 60(6):1481-1484.
63. Francis D., Diorio J., LaPlante P., Weaver S., Seckl J.R., Meaney M.J. The role of early environmental events in regulating neuroendocrine development. moms, pups, stress, and glucocorticoid receptors. Ann. NY Acad. Sci. 1996, 794:136-152.
64. Gabriel K.I., Glavas M.M., Ellis L.I., Weinberg J. Postnatal handling does not normalize corticotropin releasing factor mRNA levels in animals prenatally exposed to ethanol. Dev. Brain Res. 2005, 157:74-82.
65. Gabriel K.I., Yu C.L., Osborn J.A., Weinberg J. Prenatal ethanol exposure alters sensitivity to the effects of corticotropin-releasing factor (CRF) on behavior in the elevated plus-maze. Psychoneuroendocrinology 2006, 31(9):1046-1056.
66. Gallo P.V., Weinberg J. Corticosterone rhythmicity in the rat: interactive effects of dietary restriction and schedule of feeding. J. Nutr. 1981, 111(2):208-218.
67. Gallo P.V., Weinberg J. Neuromotor development and response inhibition following prenatal ethanol exposure. Neurobehav. Toxicol. Teratol. 1982, 4(5):505-513.
68. Gerra G., Leonardi C., Cortese E., Zaimovic A., Dell'agnello G., Manfredini M., et al. Childhood neglect and parental care perception in cocaine addicts: relation with psychiatric symptoms and biological correlates. Neurosci. Biobehav. Rev. 2007.
69. Geyer M.A., Markou A. Animal models of psychiatric disorders. Psychopharmacology-The 4th Generation of Progress 1995, 787-798. Raven, New York. F.E. Bloom, D.J. Kupfer (Eds.).
70. Gibbons J.L. Cortisol secretion rate in depressive illness. Arch. Gen. Psychiatry 1964, 10:572-575.
71. Gilman S.E., Kawachi I., Fitzmaurice G.M., Buka S.L. Socioeconomic status in childhood and the lifetime risk of major depression. Int. J. Epidemiol. 2002, 31(2):359-367.
72. Gilman S.E., Kawachi I., Fitzmaurice G.M., Buka S.L. Family disruption in childhood and risk of adult depression. Am. J. Psychiatry 2003, 160(5):939-946.
73. Glavas M.M., Yu W.K., Weinberg J. Effects of mineralocorticoid and glucocorticoid receptor blockade on hypothalamic-pituitary-adrenal function in female rats prenatally exposed to ethanol. Alcohol. Clin. Exp. Res. 2006, 30(11):1916-1924.
74. Glavas M.M., Ellis L., Yu W.K., Weinberg J. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone. Alcohol. Clin. Exp. Res. 2007, 31:598-610.
75. Glavas M.M., Hofmann C.E., Yu W.K., Weinberg J. Effects of prenatal ethanol exposure on hypothalamic-pituitary-adrenal regulation after adrenalectomy and corticosterone replacement. Alcohol. Clin. Exp. Res. 2001, 25(6):890-897.
76. Gluckman P.D., Hanson M.A. The developmental origins of the metabolic syndrome. Trends Endocrinol. Metab. 2004, 15(4):183-187.
77. Goeders N.E. The impact of stress on addiction. Eur. Neuropsychopharmacol. 2003, 13(6):435-441.
78. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol. Psychiatry 2002, 7(3):254-275.
79. Gorman J.M. Comorbid depression and anxiety spectrum disorders. Depress. Anxiety 1996, 4(4):160-168.
80. Gutman D.A., Nemeroff C.B. Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies. Physiol. Behav. 2003, 79(3):471-478.
81. Halbreich U., Asnis G.M., Shindledecker R., Zumoff B., Nathan R.S. Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch. Gen. Psychiatry 1985, 42(9):904-908.
82. Halbreich U., Asnis G.M., Shindledecker R., Zumoff B., Nathan R.S. Cortisol secretion in endogenous depression. II. Time-related functions. Arch. Gen. Psychiatry 1985, 42(9):909-914.
83. Haley D.W., Handmaker N.S., Lowe J. Infant stress reactivity and prenatal alcohol exposure. Alcohol. Clin. Exp. Res. 2006, 30(12):2055-2064.
84. Harkness K.L., Monroe S.M. Childhood adversity and the endogenous versus nonendogenous distinction in women with major depression. Am. J. Psychiatry 2002, 159(3):387-393.
85. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284(5):592-597.
86. Heinrichs S.C., Menzaghi F., Merlo Pich E., Britton K.T., Koob G.F. The role of CRF in behavioral aspects of stress. Ann. NY Acad. Sci. 1995, 771:92-104.
87. Hellemans K., Verma P., Yoon E., Yu W., Weinberg J. Prenatal alcohol exposure increases vulnerability to stress and anxiety-like disorders in adulthood. Ann. NY Acad. Sci. 2008, 1144:154-175.
88. Heuser I., Yassouridis A., Holsboer F.J. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Psychiatr. Res. 1994, 28(4):341-356.
89. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur. Psychiatry 2002, 17(Suppl. 3):294-299.
90. Hofmann C., Glavas M., Yu W., Weinberg J. Glucocorticoid fast feedback is not altered in rats prenatally exposed to ethanol. Alcohol. Clin. Exp. Res. 1999, 23(5):891-900.
91. 1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol. Alcohol. Clin. Exp. Res. 2007, 31(2):345-355.
92. 1A agonist. Pharmacol. Biochem. Behav. 2005, 82(3):549-558.
93. Hofmann C.E., Simms W., Yu W.K., Weinberg J. Prenatal ethanol exposure in rats alters serotonergic-mediated behavioral and physiological function. Psychopharmacology (Berl.) 2002, 161(4):379-386.
94. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23(5):477-501.
95. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 2001, 62(1-2):77-91.
96. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(6):1085-1093.
97. Jacobs B.L., Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 2000, 5(3):262-269.
98. Jacobson S.W., Bihun J.T., Chiodo L.M. Effects of prenatal alcohol and cocaine exposure on infant cortisol levels. Dev. Psychopathol. 1999, 11:195-208.
99. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol. Behav. 1991, 49(2):245-250.
100. Jones K.L., Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973, 2(7836):999-1001.
101. Jones K.L., Smith D.W., Ulleland C.N., Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1973, 1(7815):1267-1271.
102. Jones M.T., Gillham B. Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol. Rev. 1988, 68(3):743-818.
103. Kalueff A.V., Wheaton M., Murphy D.L. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav. Brain Res. 2007, 179(1):1-18.
104. Katz M.M., Shulman R., Robins E. Behavioral aspects and relationships to outcome [proceedings]. Psychopharmacol. Bull. 1981, 17(1):69-70.
105. Kaufman J., Plotsky P.M., Nemeroff C.B., Charney D.S. Effects of early adverse experiences on brain structure and function: clinical implications. Biol. Psychiatry 2000, 48(8):778-790.
106. Keck M.E. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 2006, 31(3):241-250.
107. Kessler R.C. The effects of stressful life events on depression. Annu. Rev. Psychol. 1997, 48:191-214.
108. Kim C.K., Giberson P.K., Yu W., Weinberg J. Response to cold stress following prenatal ethanol exposure [Abstract]. Soc. Neurosci. Abstr. 1996, 22:1342.
109. Kim C.K., Osborn J.A., Weinberg J. Stress reactivity in fetal alcohol syndrome. Fetal Alcohol Syndrome: From Mechanism to Behavior 1996, 215-236. CRC Press. E. Abel (Ed.).
110. Kim C.K., Giberson P.K., Yu W., Zoeller R.T., Weinberg J. Effects of prenatal ethanol exposure on hypothalamic-pituitary-adrenal responses to chronic cold stress in rats. Alcohol. Clin. Exp. Res. 1999, 23(2):301-310.
111. Kim C.K., Kalynchuk L.E., Kornecook T.J., Mumby D.G., Dadgar N.A., Pinel J.P., et al. Object-recognition and spatial learning and memory in rats prenatally exposed to ethanol. Behav. Neurosci. 1997, 111(5):985-995.
112. Kim C.K., Turnbull A.V., Lee S.Y., Rivier C.L. Effects of prenatal exposure to alcohol on the release of adenocorticotropic hormone, corticosterone, and proinflammatory cytokines. Alcohol. Clin. Exp. Res. 1999, 23(1):52-59.
113. Kodituwakku P., Coriale G., Fiorentino D., Aragon A.S., Kalberg W.O., Buckley D., et al. Neurobehavioral characteristics of children with fetal alcohol spectrum disorders in communities from Italy: preliminary results. Alcohol. Clin. Exp. Res. 2006, 30(9):1551-1561.
114. Kodituwakku P.W. Defining the behavioral phenotype in children with fetal alcohol spectrum disorders: a review. Neurosci. Biobehav. Rev. 2007, 31(2):192-201.
115. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., Plotsky P.M. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 2000, 122:81-103.
116. Lee S., Imaki T., Vale W., Rivier C. Effect of prenatal exposure to ethanol on the activity of the hypothalamic-pituitary-adrenal axis of the offspring: importance of the time of exposure to ethanol and possible modulating mechanisms. Mol. Cell. Neurosci. 1990, 1:168-177.
117. Lee S., Rivier C. Gender differences in the effect of prenatal alcohol exposure on the hypothalamic-pituitary-adrenal axis response to immune signals. Psychoneuroendocrinology 1996, 21(2):145-155.
118. Lee S., Schmidt D., Tilders F., Rivier C. Increased activity of the hypothalamic-pituitary-adrenal axis of rats exposed to alcohol in utero: role of altered pituitary and hypothalamic function. Mol. Cell. Neurosci. 2000, 16(4):515-528.
119. Leichter J., Lee M. Effect of maternal ethanol administration on physical growth of the offspring in rats. Growth 1979, 43(4):288-293.
120. Lemoine P., Harousseau H., Borteyru J.P., Menuet J.C. Children of alcoholic parents-observed anomalies: discussion of 127 cases. Ther. Drug Monit. 2003, 25(2):132-136.
121. Lenze E.J., Mulsant B.H., Shear M.K., Alexopoulos G.S., Frank E., Reynolds C.F. Comorbidity of depression and anxiety disorders in later life. Depress. Anxiety 2001, 14(2):86-93.
122. Levitan R.D., Rector N.A., Sheldon T., Goering P. Childhood adversities associated with major depression and/or anxiety disorders in a community sample of Ontario: issues of co-morbidity and specificity. Depress. Anxiety 2003, 17(1):34-42.
123. Lifschytz T., Shalom G., Lerer B., Newman M.E. Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. Eur. Neuropsychopharmacol. 2006, 16(2):115-121.
124. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 1987, 92(2):180-185.
125. Lloyd A.J., Ferrier I.N., Barber R., Gholkar A., Young A.H., O'Brien J.T. Hippocampal volume change in depression: late- and early-onset illness compared. Br. J. Psychiatry 2004, 184:488-495.
126. Lochry E.A., Riley E.P. Retention of passive avoidance and T-maze escape in rats exposed to alcohol prenatally. Neurobehav. Toxicol. 1980, 2:107-115.
127. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett research award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 1998, 43(8):547-573.
128. MacMillan H.L., Fleming J.E., Streiner D.L., Lin E., Boyle M.H., Jamieson E., et al. Childhood abuse and lifetime psychopathology in a community sample. Am. J. Psychiatry 2001, 158(11):1878-1883.
129. Mannie Z.N., Harmer C.J., Cowen P.J. Increased waking salivary cortisol levels in young people at familial risk of depression. Am. J. Psychiatry 2007, 164(4):617-621.
130. Manning M.A., Hoyme H.E. Fetal alcohol spectrum disorders: a practical clinical approach to diagnosis. Neurosci. Biobehav. Rev. 2007, 31(2):230-238.
131. Maren S. Building and burying fear memories in the brain. Neuroscientist 2005, 11(1):89-99.
132. Martin J.C., Martin D.C., Sigman G., Radow B. Maternal ethanol consumption and hyperactivity in cross-fostered offspring. Physiol. Psychol. 1978, 6:362-365.
133. Matthews K., Christmas D., Swan J., Sorrell E. Animal models of depression: navigating through the clinical fog. Neurosci. Biobehav. Rev. 2005, 29(4-5):503-513.
134. Matthews K., Forbes N., Reid I.C. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol. Behav. 1995, 57(2):241-248.
135. Matthews S.G. Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res. 2000, 47(3):291-300.
136. Matthews S.G., Owen D., Banjanin S., Andrews M.H. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr. Res. 2002, 28(4):709-718.
137. Mattson S.N., Schoenfeld A.M., Riley E.P. Teratogenic effects of alcohol on brain and behavior. Alcohol. Res. Health 2001, 25(3):185-191.
138. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 1997, 9(3):471-481.
139. McArthur R., Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacol. Biochem. Behav. 2006, 84(3):436-452.
140. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. NY Acad. Sci. 2004, 1032:1-7.
141. McKinney W.T., Bunney W.E. Animal model of depression. I. Review of evidence: implications for research. Arch. Gen. Psychiatry 1969, 21(2):240-248.
142. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 2001, 24:1161-1192.
143. Mineka S., Watson D., Clark L.A. Comorbidity of anxiety and unipolar mood disorders. Annu. Rev. Psychol. 1998, 49:377-412.
144. Mothes H.K., Opitz B., Werner R., Clausing P. Effects of prenatal ethanol exposure and early experience on home-cage and open-field activity in mice. Neurotoxicol. Teratol. 1996, 18(1):59-65.
145. 1A receptor binding in people with panic disorder: positron emission tomography study. Br. J. Psychiatry 2008, 193(3):229-234.
146. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry 2005, 66(Suppl. 7):5-13.
147. Nemeroff C.B. Comorbidity of mood and anxiety disorders: the rule, not the exception?. Am. J. Psychiatry 2002, 159(1):3-4.
148. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 1988, 45(6):577-579.
149. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34(1):13-25.
150. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59(12):1151-1159.
151. Nunes E.V., Rounsaville B.J. Comorbidity of substance use with depression and other mental disorders: from diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) to DSM-V. Addiction 2006, 101(Suppl. 1):89-96.
152. Nutt D.J. Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatry 2008, 69(Suppl. E1):4-7.
153. Nutt D.J., Stein D.J. Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr. 2006, 11(10 Suppl. 12):13-20.
154. O'Connor M.J., Kasari C. Prenatal alcohol exposure and depressive features in children. Alcohol. Clin. Exp. Res. 2000, 24(7):1084-1092.
155. O'Connor M.J., Paley B. The relationship of prenatal alcohol exposure and the postnatal environment to child depressive symptoms. J. Pediatr. Psychol. 2006, 31(1):50-64.
156. O'Connor M.J., Shah B., Whaley S., Cronin P., Gunderson B., Graham J. Psychiatric illness in a clinical sample of children with prenatal alcohol exposure. Am. J. Drug Alcohol Abuse 2002, 28(4):743-754.
157. O'Connor T.M., O'Halloran D.J., Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM 2000, 93(6):323-333.
158. Olson H.C., Morse B.A., Huffine C. Development and psychopathology: fetal alcohol syndrome and related conditions. Semin. Clin. Neuropsychiatry 1998, 3(4):262-284.
159. O'Malley K.D., Nanson J. Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder. Can. J. Psychiatry 2002, 47(4):349-354.
160. Osborn J.A., Kim C.K., Steiger J., Weinberg J. Prenatal ethanol exposure differentially alters behavior in males and females on the elevated plus maze. Alcohol. Clin. Exp. Res. 1998, 22(3):685-696.
161. Osborn J.A., Kim C.K., Yu W., Herbert L., Weinberg J. Fetal ethanol exposure alters pituitary-adrenal sensitivity to dexamethasone suppression. Psychoneuroendocrinology 1996, 21(2):127-143.
162. Osborn J.A., Yu C., Gabriel K., Weinberg J. Fetal ethanol effects on benzodiazepine sensitivity measured by behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 1998, 60(3):625-633.
163. Osborn J.A., Yu C., Stelzl G.E., Weinberg J. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues. Alcohol. Clin. Exp. Res. 2000, 24(7):1110-1119.
164. Palanza P. Animal models of anxiety and depression: how are females different?. Neurosci. Biobehav. Rev. 2001, 25(3):219-233.
165. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm. Behav. 2003, 43(1):60-66.
166. Patchev V.K., Hayashi S., Orikasa C., Almeida O.F. Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitary-adrenal regulation. FASEB J. 1995, 9(5):419-423.
167. Pellow S., Chopin P., File S.E., Briley M. Validation of open:Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14(3):149-167.
168. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 1986, 24(3):525-529.
169. Pettinati H.M. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol. Psychiatry 2004, 56(10):785-792.
170. Phillips D.I., Barker D.J., Fall C.H., Seckl J.R., Whorwood C.B., Wood P.J., et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J. Clin. Endocrinol. Metab. 1998, 83(3):757-760.
171. Phillips D.I., Walker B.R., Reynolds R.M., Flanagan D.E., Wood P.J., Osmond C., et al. Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 2000, 35(6):1301-1306.
172. Placidi G.P., Oquendo M.A., Malone K.M., Huang Y.Y., Ellis S.P., Mann J.J. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol. Psychiatry 2001, 50(10):783-791.
173. Porsolt R.D. Animal model of depression. Biomedicine 1979, 30(3):139-140.
174. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47(4):379-391.
175. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463(1-3):3-33.
176. Pryce C.R., Feldon J. Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci. Biobehav. Rev. 2003, 27(1-2):57-71.
177. Pryce C.R., Ruedi-Bettschen D., Dettling A.C., Weston A., Russig H., Ferger B., et al. Long-term effects of early-life environmental manipulations in rodents and primates: potential animal models in depression research. Neurosci. Biobehav. Rev. 2005, 29(4-5):649-674.
178. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J. Neurosci. 2004, 24(14):3471-3479.
179. Ramsay D.S., Bendersky M.I., Lewis M. Effect of prenatal alcohol and cigarette exposure on two- and six-month-old infants' adrenocortical reactivity to stress. J. Pediatr. Psychol. 1996, 21(6):833-840.
180. Randall C.L., Taylor J., Walker D.W. Ethanol-induced malformations in mice. Alcohol. Clin. Exp. Res. 1977, 1(3):219-224.
181. Rathbun W., Druse M.J. Dopamine, serotonin, and acid metabolites in brain regions from the developing offspring of ethanol-treated rats. J. Neurochem. 1985, 44(1):57-62.
182. Redei E., Clark W.R., McGivern R.F. Alcohol exposure in utero results in diminished T-cell function and alterations in brain corticotropin-releasing factor and ACTH content. Alcohol. Clin. Exp. Res. 1989, 13(3):439-443.
183. Redei E., Halasz I., Li L.F., Prystowsky M.B., Aird F. Maternal adrenalectomy alters the immune and endocrine functions of fetal alcohol-exposed male offspring. Endocrinology 1993, 133(2):452-460.
184. Redei E.E., Ahmadiyeh N., Baum A.E., Sasso D.A., Slone J.L., Solberg L.C., et al. Novel animal models of affective disorders. Semin. Clin. Neuropsychiatry 2001, 6(1):43-67.
185. Riley E.P., Baron S., Hannigan J.H. Response inhibition deficits following prenatal alcohol exposure: a comparison to the effects of hippocampal lesions in rats. Alcohol and Brain Development 1986, 7-102. Oxford University Press, New York. J.R. West (Ed.).
186. Riley E.P., Lochry E.A., Shapiro N.R. Lack of response inhibition in rats prenatally exposed to alcohol. Psychopharmacology (Berl.) 1979, 62(1):47-52.
187. Riley E.P., McGee C.L. Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp. Biol. Med. (Maywood) 2005, 230(6):357-365.
188. Rivier C.L., Plotsky P.M. Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu. Rev. Physiol. 1986, 48:475-494.
189. Roebuck T.M., Mattson S.N., Riley E.P. Behavioral and psychosocial profiles of alcohol-exposed children. Alcohol. Clin. Exp. Res. 1999, 23(6):1070-1076.
190. Root A.W., Reiter E.O., Andriola M., Duckett G. Hypothalamic-pituitary function in the fetal alcohol syndrome. J. Pediatr. 1975, 87(4):585-588.
191. Sadowski H., Ugarte B., Kolvin I., Kaplan C., Barnes J. Early life family disadvantages and major depression in adulthood. Br. J. Psychiatry 1999, 174:112-120.
192. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21(1):55-89.
193. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol. Psychiatry 2001, 50(3):159-170.
194. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 1965, 122(5):509-522.
195. Schneider M.L., Moore C.F., Kraemer G.W., Roberts A.D., DeJesus O.T. The impact of prenatal stress, fetal alcohol exposure, or both on development: perspectives from a primate model. Psychoneuroendocrinology 2002, 27(1-2):285-298.
196. Shaywitz S.E., Cohen D.J., Shaywitz B.A. Behavior and learning difficulties in children of normal intelligence born to alcoholic mothers. J. Pediatr. 1980, 96(6):978-982.
197. Shekhar A., Truitt W., Rainnie D., Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 2005, 8(4):209-219.
198. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(9):3908-3913.
199. Sliwowska J.H., Lan N., Yamashita F., Halpert A.G., Ellis L., Weinberg J. Effects of prenatal ethanol exposure on basal hypothalamic-pituitary-adrenal activity and hippocampal 5-HT1A receptor mRNA levels in female rats across the estrous cycle. Psychoneuroendocrinology 2008, 33(8):1111-1123.
200. Slone J.L., Redei E.E. Maternal alcohol and adrenalectomy: asynchrony of stress response and forced swim behavior. Neurotoxicol. Teratol. 2002, 24:173-178.
201. Steinhausen H.C., Spohr H.L. Long-term outcome of children with fetal alcohol syndrome: psychopathology, behavior, and intelligence. Alcohol. Clin. Exp. Res. 1998, 22(2):334-338.
202. Fetal Alcohol Syndrome-Diagnosis, Epidemiology, Prevention and Treatment 1996, Institute of Medicine, National Academy of Sciences, Washington, DC. K. Stratton, C. Howe, F. Battaglia (Eds.).
203. Streissguth A.P. The behavioral teratology of alcohol: performance, behavioral and intellectual deficits in prenatally exposed children. Alcohol and Brain Development 1986, 3-44. Oxford University Press, New York. J.R. West (Ed.).
204. Streissguth, A.P., Barr, H.M., Kogan, J., Bookstein, F.L. 1996. Understanding the occurrence of secondary disabilities in clients with fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE). Final Report, Centers for Disease Control and Prevention Grant No. RO4/CCR008515. University of Washington Publication Services, Seattle, WA.
205. Streissguth A.P., Bookstein F.L., Barr H.M., Sampson P.D., O'Malley K., Young J.K. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J. Dev. Behav. Pediatr. 2004, 25(4):228-238.
206. Streissguth A.P., O'Malley K. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin. Clin. Neuropsychiatry 2000, 5(3):177-190.
207. Strickland P., Deakin J.F.W. Cortisol, stress and depression (authors' reply). Br. J. Psychiatry 2002, 181:348-349.
208. Subcommittee on Laboratory Animal Nutrition, Committee on Animal Nutrition, Board on Agriculture, and National Research Council Nutrient Requirements of Laboratory Animals 1995, National Academy, Washington, DC. Fourth revised edition.
209. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005, 4(2):141-194.
210. Symonds M.E., Stephenson T., Gardner D.S., Budge H. Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. Reprod. Fertil. Dev. 2007, 19(1):53-63.
211. Tajuddin N.F., Druse M.J. Treatment of pregnant alcohol-consuming rats with buspirone: effects on serotonin and 5-hydroxyindoleacetic acid content in offspring. Alcohol. Clin. Exp. Res. 1993, 17(1):110-114.
212. Taylor A.N., Branch B.J., van Zuylen J.E., Redei E. Maternal alcohol consumption and stress responsiveness in offspring. Mechanisms of Physical and Emotional Stress. Advances in Experimental Medicine and Biology 1988, vol. 245:311-317. Plenum Press, New York.
213. Taylor A.N., Branch B.J., Kokka N., Poland R.E. Neonatal and long-term neuroendocrine effects of fetal alcohol exposure. Monogr. Neural Sci. 1983, 9:140-152.
214. Taylor A.N., Branch B.J., Liu S.H., Kokka N. Long-term effects of fetal ethanol exposure on pituitary-adrenal response to stress. Pharmacol. Biochem. Behav. 1982, 16(4):585-589.
215. Thayer J.F., Lane R.D. A model of neurovisceral integration in emotion regulation and dysregulation. J. Affect. Disord. 2000, 61(3):201-216.
216. Trivedi M.H., Hollander E., Nutt D., Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J. Clin. Psychiatry 2008, 69(2):246-258.
217. van Praag H.M., Kahn R.S. L-5-hydroxytryptophan in depression and anxiety. Schweiz. Rundsch. Med. Prax. 1988, 77(34A):40-46.
218. van Praag H.M., Plutchik R. Increased suicidality in depression: group or subgroup characteristic?. Psychiatry Res. 1988, 26(3):273-278.
219. Vieau D., Sebaai N., Leonhardt M., Dutriez-Casteloot I., Molendi-Coste O., Laborie C., Breton C., Deloof S., Lesage J. HPA axis programming by maternal undernutrition in the male rat offspring. Psychoneuroendocrinology 2007, 32(Suppl. 1):S16-S20.
220. Walsh B.T., Seidman S.N., Sysko R., Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002, 287(14):1840-1847.
221. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol. Bull. 1976, 83(3):482-504.
222. Watson S., Gallagher P., Ritchie J.C., Ferrier I.N., Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 2004, 184:496-502.
223. Watson S., Gallagher P., Smith M.S., Ferrier I.N., Young A.H. The dex/CRH test--is it better than the DST?. Psychoneuroendocrinology 2006, 31(7):889-894.
224. Weinberg, J., 1993. Prenatal alcohol exposure: endocrine function of offspring. In: Zakhari, S. (Ed.), Alcohol and the Endocrine System. Research Monograph No 23. NIH (NIAAA), Bethesda, MD, pp. 363-382.
225. Weinberg, J., 1995. In utero alcohol exposure and hypothalamic-pituitary-adrenal activity: gender differences in outcome. In: Zakhari, S., Hunt, W.A. (Eds.), Stress, Gender and Alcohol-seeking Behavior. Research Monograph 29. National Institute on Alcohol Abuse and Alcoholism, Bethesda, pp. 241-256.
226. Weinberg J., Nelson L.R., Taylor A.N. Hormonal effects of fetal alcohol exposure. Alcohol and Brain Development 1986, 310-342. Oxford University Press, New York. J.R. West (Ed.).
227. Weinberg J. Nutritional issues in perinatal alcohol exposure. Neurobehav. Toxicol. Teratol. 1984, 6(4):261-269.
228. Weinberg J. Effects of ethanol and maternal nutritional status on fetal development. Alcohol. Clin. Exp. Res. 1985, 9(1):49-55.
229. Weinberg J. Hyperresponsiveness to stress: differential effects of prenatal ethanol on males and females. Alcohol. Clin. Exp. Res. 1988, 12(5):647-652.
230. Weinberg J. Prenatal ethanol exposure alters adrenocortical development of offspring. Alcohol. Clin. Exp. Res. 1989, 13(1):73-83.
231. Weinberg J. Prenatal ethanol effects: sex differences in offspring stress responsiveness. Alcohol 1992, 9(3):219-223.
232. Weinberg J. Prenatal ethanol exposure alters adrenocortical response to predictable and unpredictable stressors. Alcohol 1992, 9(5):427-432.
233. Weinberg J. Neuroendocrine effects of prenatal alcohol exposure. Ann. NY Acad. Sci. 1993, 697:86-96.
234. Weinberg J., Gallo P.V. Prenatal ethanol exposure: pituitary-adrenal activity in pregnant dams and offspring. Neurobehav. Toxicol. Teratol. 1982, 4(5):515-520.
235. Weinberg J., Sliwowska J.H., Lan N., Hellemans K.G. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J. Neuroendocrinol. 2008, 20:470-488.
236. Weinberg J., Taylor A.N., Gianoulakis C. Fetal ethanol exposure: hypothalamic-pituitary-adrenal and beta-endorphin responses to repeated stress. Alcohol. Clin. Exp. Res. 1996, 20(1):122-131.
237. Welberg L.A., Seckl J.R. Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 2001, 13(2):113-128.
238. Wigger A., Neumann I.D. Periodic maternal deprivation induces gender-dependent alterations in behavioral and neuroendocrine responses to emotional stress in adult rats. Physiol. Behav. 1999, 66(2):293-302.
239. Wilcoxon J.S., Redei E.E. Maternal glucocorticoid deficit affects hypothalamic-pituitary-adrenal function and behavior of rat offspring. Horm. Behav. 2007, 51(3):321-327.
240. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl.) 1997, 134(4):319-329.
241. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52(2):90-110.
242. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(1):325-330.
243. Young A.H. Cortisol in mood disorders. Stress 2004, 7(4):205-208.
244. Young A.H. Antiglucocoticoid treatments for depression. Aust. N. Z. J. Psychiatry 2006, 40(5):402-405.
245. Young E.A., Abelson J.L., Cameron O.G. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol. Psychiatry 2004, 56(2):113-120.
246. Young E.A., Altemus M. Puberty, ovarian steroids, and stress. Ann. NY Acad. Sci. 2004, 1021:124-133.
247. Zafar H., Shelat S.G., Redei E., Tejani-Butt S. Fetal alcohol exposure alters serotonin transporter sites in rat brain. Brain Res. 2000, 856(1-2):184-192.
248. Zilberman M.L., Tavares H., Blume S.B., el-Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can. J. Psychiatry 2003, 48(1):5-13.